Plum SEC
Menu
Korean Market
Privacy Policy
Korean Market
Star Rating
Reset (View All)
★★★★★
★★★★
★★★
★★
★
★
★
★★
★★★
★★★★
★★★★★
All Disclosures
Search
EXCH
Amicogen
★
Conversion Price of 6th CB Adjusted Downward from 3,848 Won to 2,694 Won, Increasing Potential Dilution Risk for Shareholders
06/02/2026, 04:22 AM
EXCH
Amicogen
★★
Acquisition of 1.05 billion won convertible bonds before maturity, conversion price adjusted to 2,908 won
05/16/2026, 07:51 PM
EXCH
Amicogen
★
Conversion Price Adjusted from 3,104 to 2,908 Won & 500M Won Bond Early Acquisition
05/16/2026, 07:51 PM
EXCH
Amicogen
★
Early Acquisition of KRW 61.68 Billion 4th Series Convertible Bonds (Reflecting Conversion Price Adjustment to 3,729 Won)
05/16/2026, 07:51 PM
PERI
Amicogen
★
Amicogen 2026 Q1: Revenue up, operating loss narrows, net profit swings to black on one-time gains
05/14/2026, 04:19 PM
OWNR
Amicogen
★
Maga Partners Investment Union Reports 4.28% Stake
05/04/2026, 05:15 PM
OWNR
Amicogen
★
Change in Shareholding by Executives/Major Shareholders: Reduction of 100,000 Shares via Contribution
05/04/2026, 05:09 PM
PERI
Amicogen
★★
Amicogen Corrects Audit Report: Net Assets and Net Loss Increased Due to Subsidiary Impairment Error
05/03/2026, 07:00 AM
PERI
Amicogen
★★★
Amicogen Corrects Financials: Net Loss Increases, Equity Decreases
05/03/2026, 07:00 AM
PERI
Amicogen
★★★
Amicogen Q3 Consolidated Operating Loss of KRW 13.3B, Asset Restatement Reduces Equity by KRW 7.6B
05/03/2026, 07:00 AM
PERI
Amicogen
★★★
Amicogen Reports Continued Losses, Financial Restatement, and Major Shareholder Change
05/03/2026, 07:00 AM
PERI
Amicogen
★★★
Amicogen Corrects Business Report: Understated Impairment Loss on Puriogen Increases Net Loss by KRW 7.6B
05/03/2026, 07:00 AM
PERI
Amicogen
★★★
Amicogen Corrects Quarterly Report: Recognizes Subsidiary Investment Impairment, Operating Loss Continues
05/03/2026, 07:00 AM